Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 Days
Clinical trial NCT01736462 · COMPLETED
Trial details
- NCT number
- NCT01736462
- Sponsor
- Bausch & Lomb Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2013-07-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.